Host Immune and Intestinal Barrier Pathways

The Host Immune and Intestinal Barrier Pathways represent a complex physiological system essential for maintaining gastrointestinal homeostasis and systemic health. This system comprises the physical epithelial barrier, the chemical mucus layer, and the gut-associated lymphoid tissue (GALT), which collectively prevent the translocation of harmful pathogens while allowing nutrient absorption [1]. The intestinal epithelial cells are linked by tight junction proteins, such as claudins and occludin, which regulate paracellular permeability and are vital for structural integrity [2]. Dysregulation of these pathways, often referred to as 'leaky gut,' is a central feature of inflammatory bowel diseases (IBD), where impaired barrier function leads to an exaggerated immune response against commensal microbiota [3]. Therapeutic interventions targeting these pathways include biologics that neutralize pro-inflammatory cytokines like TNF-alpha and IL-12/23, as well as small molecules that inhibit JAK signaling or prevent leukocyte migration to the gut [4]. Emerging research also focuses on directly reinforcing the barrier through the modulation of tight junction proteins and the enhancement of the protective mucus layer to restore the frontier between the host and the environment [5]. (Sources: [1] Bischoff SC, et al. BMC Gastroenterology, 2014; [2] Okumura R, Takeda K. Nature Reviews Immunology, 2017; [3] Neurath MF. Nature Reviews Immunology, 2014; [4] Mehandru S, Colombel JF. Immunity, 2021; [5] Chelakkot C, et al. Experimental & Molecular Medicine, 2018).

Other names

Gut-immune axisIntestinal mucosal barrierGut barrier functionMucosal immunityIntestinal epithelial barrier

Modulation of cytokine signaling (e.g., TNF, IL-12/23 inhibition), blockade of leukocyte trafficking (e.g., alpha-4-beta-7 integrin antagonism), and reinforcement of epithelial tight junction integrity.